Can you trust your generic fingolimod prescription? Find our more at ow.ly/nm4w50ZQA5S

We're thrilled to be attending the American Society of Nephrology- Kidney Week meeting 2026! If you're attending please don't hesitate to stop by booth #983 to meet our team this week.

Find out more about the Bafiertam difference at ow.ly/YBVU50ZQzHo

Can you trust your generic fingolimod prescription? Find our more at ow.ly/70NK50ZQzus

A treatment that works with life. PHYRAGO is a proven treatment for Ph+ CML and Ph+ ALL, offering the convenience of once-daily dosing and the flexibility to be taken with or without food. Get in touch with Cycle Vita at [email protected] or call 888-360-8482.

Introducing Cycle Vita Low PRO™, an award-winning diet tracking app designed to support people managing low-protein diets across rare diseases, including phenylketonuria (PKU), Hereditary tyrosinemia type 1 (HT-1), Alkaptonuria (AKU) and Cystinuria. 👉 cyclevitalow.pro/

PHYRAGO is an established treatment for Ph+ CML and Ph+ ALL, providing the convenience of once-daily dosing and the flexibility to be taken with or without food. For further information, please contact Cycle Vita at [email protected] or call 888-360-8482.

We're proud to sponsor the Leukemia Research Foundation's upcoming webinar, After the Diagnosis: Finding Your Path Forward, as part of Leukemia Awareness Month. Register your interest here: leukemiarf.org/patients/webi…

Today, Cycle Pharmaceuticals launched KnowingAKU, a dedicated patient-facing platform designed to empower people living with alkaptonuria (AKU) by providing access to trusted information, practical resources, and guidance throughout their journey with this ultra-rare condition.

Cycle Pharmaceuticals has launched CAVHANZA™ (nilotinib) ODT, a new treatment option for patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Learn more: cavhanza.com/

Cystinuria Awareness Day is June 24! #cystinuria is a rare, serious genetic disorder characterized by frequent and recurrent #kidney stone formation. Learn more at cystinuria.org! #CystinuriaDay2024 #rarekidneystones #rarediseaseawareness

New treatment option for patients with Philadelphia chromosome‑positive chronic myeloid leukemia (Ph+ CML), designed to allow for concomitant use with proton pump inhibitors (PPIs) and H2 receptor antagonists (H₂RAs) and with no mealtime restrictions. ow.ly/VmOV50Z6Kt5

Join us live on Tuesday, June 9 | 11 am - 12 pm ET for our educational webinar: Scientific Perspectives on Fumarate Transitions in MS: A Clinical Review of Monomethyl Fumarate (MMF) Data and Observations Secure your place here 👉 ow.ly/6RpB50Z1wm4

Come and meet the new Metabolic team at booth 103-105 to learn more about how we are working to improve the care of patients in the field. We look forward to seeing you there! #GMDI2026 #GMDIConference #GMDI26

AAAAI Annual Meeting 2026 – that’s a wrap! 👏 These past few days have been filled with meaningful connections, insightful conversations, and of course, lots of fun. Thank you to everyone who came out and spent time with our immunology team.

When we asked our team, “What does supporting Cycle Pharma’s rare disease mission mean to you?” the responses spoke volumes. Today we spotlight those living with conditions that are often invisible to others, and stand with them throughout their journey. #RareDiseaseDay

We’re live at the AAAAI’s Annual Meeting 2026 in Philadelphia, PA! Want to hear how we could help your patients? Come over to booth 1545 and learn more about us and how we provide quality treatment and patient care in the field of immunology. #AAAAI2026